Untitled Page
Main Menu
Home > Equity > News Analysis > Hot Pursuit
25 November 2017

Hot Pursuit

Prev Next
24-Nov-2017 (15:29)
RBL Bank gains after large bulk deal

Meanwhile, the S&P BSE Sensex was up 115.99 points, or 0.35% to 33,704.07

Bulk deal boosted volume on the scrip. On the BSE, 67.15 lakh shares were traded in the counter so far, compared with average daily volumes of 4.31 lakh shares in the past one quarter. The stock had hit a high of Rs 525.75 and a low of Rs 510 so far during the day. The stock hit a record high of Rs 600 on 3 May 2017. The stock hit a 52-week low of Rs 325.65 on 28 December 2016.

The stock had underperformed the market over the past one month till 23 October 2017, falling 3.17% compared with 1.83% rise in the Sensex. The scrip also underperformed the market in past one quarter, declining 0.39% as against Sensex's 0.86% rise. The scrip, however, outperformed the market in past one year, surging 50.17% as against Sensex's 15.36% rise.

The large-cap company has equity capital of Rs 416.38 crore. Face value per share is Rs 10.

RBL Bank's net profit rose 67.56% to Rs 150.62 crore on 24.4% growth in total income to Rs 1332.36 crore in Q2 September 2017 over Q2 September 2016.

RBL Bank is one of India's fastest growing private sector banks with an expanding presence across the country. The bank offers specialized services under six business verticals namely: corporate & institutional banking, commercial banking, branch & business banking, agribusiness banking, development banking and financial inclusion, treasury and financial markets operations.


24-Nov-2017 (15:04)
Volumes jump at RBL Bank counter
24-Nov-2017 (14:58)
M&M gains after collaboration with Uber
24-Nov-2017 (14:30)
Indian Hume Pipe jumps on winning order
24-Nov-2017 (14:05)
Kesar Terminals sinks after subdued Q2 outcome
24-Nov-2017 (13:21)
Crompton Greaves Consumer Electricals leads gainers on BSE's 'A' group
24-Nov-2017 (12:56)
Star Paper Mills cracks after poor Q2 result
24-Nov-2017 (12:43)
Lakshmi Vilas Bank drops on profit booking
24-Nov-2017 (12:26)
Arrow Greentech gains about 9% in two sessions
24-Nov-2017 (11:38)
Cadila Healthcare rises after USFDA approval for a drug
Toll Free number: 1800-425-5501 / 1800-103-5501